Nkarta, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
NKTX chart
What traders are saying about $NKTX
Latest postsNkarta, Inc. news
- Nkarta, Inc. (NKTX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Needham maintains Nkarta at Buy, keeps price target at $11
TradingView ·
- H.C. Wainwright Maintains Nkarta(NKTX.US) With Buy Rating, Maintains Target Price $12
Moomoo ·
- Form 8K Nkarta Inc For: 9 November By Investing.com
Investing.com India ·
- NKTX: Nkarta Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Quantisnow ·
- Nkarta (NKTX) Reveals Initial Phase 1/2 Ntrust Trial Results for NKX019 in Myositis and Systemic Sclerosis
Kalkine Media ·
- Nkarta Reports Initial NKX019 Clinical Responses in Myositis and Systemic Sclerosis Trials
investorshub.advfn.com ·
- Nkarta reports early trial data for autoimmune cell therapy By Investing.com
Investing.com South Africa ·
- Nkarta Autoimmune Disease Cell Therapy’s First Human Data Show Safety, Signs of Efficacy
MedCity News ·
- Nkarta shares early NKX019 data in myositis and systemic sclerosis
StreetInsider ·
- Nkarta, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
- Nkarta Announces Initial Clinical Data for NKX019 in Myositis and Systemic Sclerosis at ACR Convergence
Yahoo Finance ·
Nkarta, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | – | – |
| Net income | -$104.1M | -$108.8M | -$117.5M | -$113.8M |
| Diluted EPS | $-1.41 | $-1.60 | $-2.40 | $-2.61 |
| Total assets (year end) | $404.2M | $501.2M | $378.9M | $472.9M |
| Cash and equivalents (year end) | $39.6M | $27.9M | $31.0M | $37.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Nkarta, Inc.
- Ticker
- NKTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1787400
Frequently asked questions
What exchange is Nkarta, Inc. listed on?
Nkarta, Inc. trades on the Nasdaq under the ticker symbol NKTX.
What industry is Nkarta, Inc. in?
Nkarta, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Nkarta, Inc. headquartered?
Nkarta, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Nkarta, Inc.'s fiscal year end?
Nkarta, Inc.'s fiscal year ends on December 31.
How much revenue did Nkarta, Inc. report?
Nkarta, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.